Comparisons of the effects of the newer atypical antipsychotics in the treatment of schizophrenia

被引：0
|
作者：
Davis, JW [1 ]
Glick, ID [1 ]
机构：
[1] UIC, Dept Psychiat, Inst Psychiat, Chicago, IL 60612 USA
来源：
SCHIZOPHRENIA RESEARCH | 1999年 / 36卷 / 1-3期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：276 / 276
页数：1
相关论文
共 50 条
  • [41] Atypical antipsychotics and cognition in schizophrenia
    Sharma, T
    ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (06) : 571 - 572
  • [42] Refractory schizophrenia and atypical antipsychotics
    Taylor, DM
    Duncan-McConnell, D
    JOURNAL OF PSYCHOPHARMACOLOGY, 2000, 14 (04) : 409 - 418
  • [43] The prognostic of schizophrenia and atypical antipsychotics
    Podea, D
    Nanu, PD
    Chenderes, RM
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S488 - S488
  • [44] Atypical antipsychotics in the treatment of subjects with schizophrenia and substance abuse disorders
    Rubio Valladolid, Gabriel
    Martinez Gras, Isabel
    SALUD I CIENCIA, 2008, 16 (04): : 387 - 390
  • [45] Meta-analytic evaluation of atypical antipsychotics for the treatment of schizophrenia
    Leucht, Stefan
    NERVENARZT, 2007, 78 : 363 - 363
  • [46] Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
    Douglas Faries
    Haya Ascher-Svanum
    Baojin Zhu
    Christoph Correll
    John Kane
    BMC Psychiatry, 5
  • [47] Pyrrolo-triazine derivatives as atypical antipsychotics for the treatment of schizophrenia
    Rasheed, Mohammed
    Shinde, Anil
    Dasoju, Meghana
    Gagginapally, Shankar Reddy
    Middekadi, Vanaja
    Subramanian, Ramkumar
    Bhyrapuneni, Gopinadh
    Jayarajan, Pradeep
    Nirogi, Venkata Satya Ramakrishna
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [48] Atypical antipsychotics in treatment-resistent schizophrenia: Risks and benefits
    Mikhnyak, SI
    Vlokh, IY
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 206 - 206
  • [49] Pharmacoeconomic comparison of ziprasidone with other atypical antipsychotics for schizophrenia treatment
    Fagiolini, Andrea
    Matone, Alice
    Gaz, Claudio
    Panunzi, Simona
    De Gaetano, Andrea
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2011, 12 (01) : 29 - 40
  • [50] Are all atypical antipsychotics equal for the treatment of cognition and affect in schizophrenia?
    Zohar, J
    CNS SPECTRUMS, 2004, 9 (10) : 5 - 5
12345